Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA warns Pfizer for unreported drug complaints
Yahoo/AP
Thursday, June 10, 2010 - 9:23am
tags:
Pfizer, side effects, FDA, warning
The Drug Passed, but the Stock Fell?
Motley Fool
Thursday, June 10, 2010 - 9:22am
tags:
Regeneron, gout, Arcalyst
ASCO Pops and Drops
Motley Fool
Wednesday, June 9, 2010 - 4:47pm
tags:
ASCO, Keryx, Ziopharm, Bristol-Myers Squibb, Pfizer, Celgene, Novartis, Amgen
Lilly CEO Addresses America's Innovation Crisis
Yahoo
Wednesday, June 9, 2010 - 2:36pm
tags:
Eli Lilly, Pharma CEOs, innovation, John Lechleiter
Delay in Medicare payment fix could mess up doctors’ federal cash flow
The Hill
Wednesday, June 9, 2010 - 9:16am
tags:
Medicare, physicians, healthcare reform
Will the Obesity Epidemic Spur a New ED Pill Just for Diabetics? One Drug Company Seems to Think So
BNET Pharma
Wednesday, June 9, 2010 - 9:15am
tags:
Vivus, obesity, diabetes, Avanafil, erectile dysfunction
Not Sold on AVI BioPharma... Yet
Seeking Alpha
Wednesday, June 9, 2010 - 8:33am
tags:
AVI BioPharma
HGS trial showed no difference in disease response
Marketwatch
Wednesday, June 9, 2010 - 8:32am
tags:
Human Genome Sciences, mapatumumab, Multiple Myeloma
Discovery Labs Reports Preliminary Results From Phase 2 Clinical Trial of Surfaxin in Pediatric Acute Respiratory Failure
Marketwatch
Wednesday, June 9, 2010 - 8:31am
tags:
pediatrics, Discovery Labs, Surfaxin, respiratory failure
Fight Brewing Over Charles River / WuXi PharmaTech Merger
Seeking Alpha
Wednesday, June 9, 2010 - 8:27am
tags:
WuXi PharmaTech, M&A, Charles River Laboratories
Forest Labs scoops up diabetes programs in $1.1B TransTech deal
Fierce Biotech
Wednesday, June 9, 2010 - 8:22am
tags:
M&A, diabetes, Forest Labs, TransTech
Bayer says to focus on growth after margins push
Reuters
Wednesday, June 9, 2010 - 8:17am
tags:
Bayer, Pharma CEOs, M&A, Marijn Dekkers
What Investors Think About Orexigen Therapeutics
Motley Fool
Wednesday, June 9, 2010 - 8:15am
tags:
investors, Orexigen
Lilly's Plan to Launch "Branded Generic" Drugs: A Blueprint for Lower Profits
BNET Pharma
Wednesday, June 9, 2010 - 8:13am
tags:
generics, Eli Lilly, Pfizer, Abbott Laboratories, branded generics, Teva Pharmaceuticals
Amgen at ASCO: Surprise! There's More to Its Story than Prolia
BNET Pharma
Wednesday, June 9, 2010 - 8:12am
tags:
Amgen, ASCO, Prolia, pancreatic cancer, ovarian cancer, pipelines
Regeneron’s $2 Billion Research Push Mimics Genentech
Bloomberg
Wednesday, June 9, 2010 - 8:11am
tags:
Regeneron, R&D, Genentech
Opko Health: Warming Up or Cooling Off?
Motley Fool
Wednesday, June 9, 2010 - 7:45am
tags:
OPKO Health
Is Allergan responsible for Botox counterfeits?
CNN/Fortune
Wednesday, June 9, 2010 - 7:43am
tags:
Allergan, Botox, drug counterfeiting
Merck reports positive results on insomnia drug
Yahoo/AP
Wednesday, June 9, 2010 - 7:42am
tags:
Merck, insomnia
Myriad Pharma plans job cuts and ends HIV program
Yahoo/AP
Wednesday, June 9, 2010 - 7:37am
tags:
HIV, Myriad, Myrexis, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.